Literature DB >> 27303238

Endocarditis and Incomplete Endothelialization 12 Years after Amplatzer Septal Occluder Deployment.

Allan K Nguyen, Brian A Palafox, Joanne P Starr, Richard N Gates, Farbouch Berdjis.   

Abstract

A 4-year-old boy had a 15-mm atrial septal defect repaired percutaneously with use of an Amplatzer Septal Occluder. At age 16 years, he presented with a week's history of fever, chills, dyspnea, fatigue, and malaise. Cultures grew methicillin-sensitive Staphylococcus aureus. A transesophageal echocardiogram showed a 1.25 × 1.5-cm pedunculated mass on the left aspect of the atrial septum just superior to the mitral valve, and a smaller vegetation on the right inferior medial aspect of the septum. At surgery, visual examination of both sides of the septum revealed granulation tissue, the pedunculated mass, the small vegetation, and exposed metal wires that suggested incomplete endothelialization of the occluder. We removed the occluder and patched the septal defect. The patient returned to full activity after 4 months and was asymptomatic 3 years postoperatively. Our report reinforces the need for further investigation into prosthetic device endothelialization, endocarditis prophylaxis, and recommended levels of physical activity in patients whose devices might be incompletely endothelialized. In addition to reporting our patient's case, we review the medical literature on this topic.

Entities:  

Keywords:  Biocompatible materials/metabolism; cardiac catheterization/instrumentation; endocarditis, bacterial/etiology/pathology/prevention & control; endothelial cells/metabolism; heart defects, congenital/therapy; heart valve prosthesis implantation/adverse effects/instrumentation/methods; prosthesis-related infections/etiology/therapy; septal occluder device/adverse effects; time factors; treatment failure

Mesh:

Substances:

Year:  2016        PMID: 27303238      PMCID: PMC4894701          DOI: 10.14503/THIJ-14-4949

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  41 in total

1.  Life-threatening isometric-exertion related cardiac perforation 5 years after Amplatzer atrial septal defect closure: should isometric activity be limited in septal occluder holders?

Authors:  Francesco Santini; Mohammed Morjan; Francesco Onorati; Giorgio Morando; Giuseppe Faggian; Alessandro Mazzucco
Journal:  Ann Thorac Surg       Date:  2012-02       Impact factor: 4.330

2.  Infective endocarditis following implantation of amplatzer atrial septal occluder.

Authors:  Ram Prakash Balasundaram; S Anandaraja; Rajnish Juneja; Shiv Kumar Choudhary
Journal:  Indian Heart J       Date:  2005 Mar-Apr

3.  Images in cardiovascular medicine. Incomplete endothelialization and late development of acute bacterial endocarditis after implantation of an Amplatzer septal occluder device.

Authors:  Timothy C Slesnick; Alan W Nugent; Charles D Fraser; Bryan C Cannon
Journal:  Circulation       Date:  2008-05-06       Impact factor: 29.690

4.  Failed endothelialisation of a percutaneous atrial septal defect closure device.

Authors:  Z Astroulakis; A El-Gamel; J M Hill
Journal:  Heart       Date:  2008-05       Impact factor: 5.994

5.  Nickel allergy induced systemic reaction to an intracardiac amplatzer device.

Authors:  Filippo Prestipino; Claudio Pragliola; Mario Lusini; Massimo Chello
Journal:  J Card Surg       Date:  2014-05       Impact factor: 1.620

6.  Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience.

Authors:  J Masura; P Gavora; A Formanek; Z M Hijazi
Journal:  Cathet Cardiovasc Diagn       Date:  1997-12

Review 7.  Infective endocarditis in congenital heart disease.

Authors:  Walter Knirsch; David Nadal
Journal:  Eur J Pediatr       Date:  2011-07-20       Impact factor: 3.183

8.  Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders.

Authors:  Jozef Masura; Pavol Gavora; Tomaz Podnar
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

9.  The molecular mechanism for effects of TiN coating on NiTi alloy on endothelial cell function.

Authors:  Dayun Yang; Xiaoying Lü; Ying Hong; Tingfei Xi; Deyuan Zhang
Journal:  Biomaterials       Date:  2014-05-10       Impact factor: 12.479

10.  Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder.

Authors:  M Burian; T Neumann; M Weber; R Brandt; G Geisslinger; V Mitrovic; C Hamm
Journal:  Int J Clin Pharmacol Ther       Date:  2006-03       Impact factor: 1.366

View more
  9 in total

1.  Assessment of the healing process after percutaneous implantation of a cardiovascular device: a systematic review.

Authors:  Elodie Perdreau; Zakaria Jalal; Richard D Walton; Jérôme Naulin; Julie Magat; Bruno Quesson; Hubert Cochet; Olivier Bernus; Jean-Benoît Thambo
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-19       Impact factor: 2.357

2.  Late Bacterial Endocarditis in an Intravenous Drug User With an Amplatzer Septal Occluder.

Authors:  Michael S La Sala; Hajir Zohourian; Joseph McKeown; Samuel Snyder
Journal:  Tex Heart Inst J       Date:  2020-08-01

3.  Angioscopic Evaluation of Atrial Septal Defect Closure Device Neo-Endothelialization.

Authors:  Yasuhiro Tanabe; Tomomi Suzuki; Shingo Kuwata; Masaki Izumo; Hiromasa Kawaguchi; Shun Ogoda; Nozomi Kotoku; Yukio Sato; Haruka Nishikawa; Toshiki Kaihara; Masashi Koga; Takanobu Mitarai; Kazuaki Okuyama; Ryo Kamijima; Yuki Ishibashi; Kihei Yoneyama; Takumi Higuma; Tomoo Harada; Yoshihiro J Akashi
Journal:  J Am Heart Assoc       Date:  2021-09-17       Impact factor: 5.501

4.  Late Infective Endocarditis Associated with an Atrial Septal Defect Occluder Device.

Authors:  Ana Milena Mejía Sanjuanelo; María Carolina Manzur Barbur; María Cristina Martínez-Ávila; Juan Camilo García Domínguez
Journal:  Eur J Case Rep Intern Med       Date:  2022-03-15

5.  A Rare Ultra-Long-Term Complication of Occluder Recanalization Due to Spontaneous Perforation of Polyvinyl Alcohol Membrane of Atrial Septal Defect Occluder: A Case Report and Review of the Literature.

Authors:  Kun Xiang; Huanwei Zhuang; Qin Wu; Mi Tang; Jinfu Yang; Chengming Fan
Journal:  Front Cardiovasc Med       Date:  2022-07-22

6.  Assessment of Device Neoendothelialization With Cardiac Computed Tomography Angiography After Transcatheter Closure of Atrial Septal Defect.

Authors:  Ah Young Kim; Wongi Woo; Beom Jin Lim; Jo Won Jung; Jae Young Choi; Young Jin Kim
Journal:  Circ Cardiovasc Imaging       Date:  2022-07-19       Impact factor: 8.589

Review 7.  Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies.

Authors:  Joop J P Kouijzer; Daniëlle J Noordermeer; Wouter J van Leeuwen; Nelianne J Verkaik; Kirby R Lattwein
Journal:  Front Cell Dev Biol       Date:  2022-10-03

8.  Key Regulatory Differentially Expressed Genes in the Blood of Atrial Septal Defect Children Treated With Occlusion Devices.

Authors:  Bo-Ning Li; Quan-Dong Tang; Yan-Lian Tan; Liang Yan; Ling Sun; Wei-Bing Guo; Ming-Yang Qian; Allen Chen; Ying-Jun Luo; Zhou-Xia Zheng; Zhi-Wei Zhang; Hong-Ling Jia; Cong Liu
Journal:  Front Genet       Date:  2021-12-08       Impact factor: 4.599

9.  Commentary: Don't leave patients to their own devices: Consider long-term complications after percutaneous atrial septal defect closure.

Authors:  Neel K Prabhu; Joseph W Turek; Nicholas D Andersen
Journal:  JTCVS Tech       Date:  2021-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.